The early diagnosis of cancer is key to survival; however, with the many demands upon the NHS this can be challenging. Speaking from the British Oncology Pharmacy Association (BOPA) 20th Annual Symposium 2017 in Glasgow, UK, Graeme Betts from the Regional Manager Health Professional Engagement Programme, Cancer Research UK, UK discusses the current landscape of cancer diagnosis and survival in the UK. Topical points covered include the survival rates of cancer patients in the UK vs. other developed nations, and the aims of CRUK in terms of cancer diagnosis and survival rates.
